![]() |
Avaliação DCF doxiMity, Inc. (documentos)
US | Healthcare | Medical - Healthcare Information Services | NYSE
|

- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Doximity, Inc. (DOCS) Bundle
Descubra o verdadeiro potencial da Doximity, Inc. (documentos) com nossa calculadora DCF avançada! Ajuste as suposições essenciais, explore vários cenários e examine como diferentes mudanças influenciam a avaliação da Doximity, Inc. (documentos) - tudo em um modelo conveniente do Excel.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 116.4 | 206.9 | 343.5 | 419.1 | 475.4 | 688.5 | 997.0 | 1,443.7 | 2,090.6 | 3,027.5 |
Revenue Growth, % | 0 | 77.76 | 66.05 | 21.98 | 13.45 | 44.81 | 44.81 | 44.81 | 44.81 | 44.81 |
EBITDA | 26.4 | 63.9 | 113.5 | 125.1 | 182.1 | 213.1 | 308.6 | 446.9 | 647.2 | 937.2 |
EBITDA, % | 22.69 | 30.89 | 33.05 | 29.86 | 38.3 | 30.96 | 30.96 | 30.96 | 30.96 | 30.96 |
Depreciation | 2.9 | 6.1 | 6.2 | 12.3 | 10.3 | 17.0 | 24.6 | 35.7 | 51.7 | 74.8 |
Depreciation, % | 2.49 | 2.97 | 1.8 | 2.94 | 2.16 | 2.47 | 2.47 | 2.47 | 2.47 | 2.47 |
EBIT | 23.5 | 57.8 | 107.3 | 112.8 | 171.8 | 196.1 | 284.0 | 411.2 | 595.5 | 862.4 |
EBIT, % | 20.2 | 27.92 | 31.24 | 26.92 | 36.14 | 28.49 | 28.49 | 28.49 | 28.49 | 28.49 |
Total Cash | 86.4 | 142.5 | 798.1 | 841.0 | 762.9 | 610.2 | 883.6 | 1,279.6 | 1,853.0 | 2,683.3 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 26.2 | 50.3 | 81.1 | 107.0 | 101.3 | 161.5 | 233.8 | 338.6 | 490.3 | 710.0 |
Account Receivables, % | 22.48 | 24.32 | 23.6 | 25.55 | 21.31 | 23.45 | 23.45 | 23.45 | 23.45 | 23.45 |
Inventories | 3.4 | 5.9 | .0 | 5.1 | .0 | 9.6 | 13.9 | 20.2 | 29.2 | 42.3 |
Inventories, % | 2.93 | 2.83 | 0 | 1.22 | 0 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 |
Accounts Payable | 1.4 | 1.5 | .5 | 1.3 | 2.3 | 3.9 | 5.7 | 8.3 | 12.0 | 17.3 |
Accounts Payable, % | 1.22 | 0.73225 | 0.13477 | 0.30354 | 0.47389 | 0.57239 | 0.57239 | 0.57239 | 0.57239 | 0.57239 |
Capital Expenditure | -4.2 | -4.6 | -5.7 | -6.2 | -5.8 | -14.1 | -20.4 | -29.5 | -42.8 | -61.9 |
Capital Expenditure, % | -3.65 | -2.23 | -1.66 | -1.48 | -1.22 | -2.05 | -2.05 | -2.05 | -2.05 | -2.05 |
Tax Rate, % | 20.31 | 20.31 | 20.31 | 20.31 | 20.31 | 20.31 | 20.31 | 20.31 | 20.31 | 20.31 |
EBITAT | 29.7 | 50.2 | 145.7 | 95.6 | 136.9 | 177.0 | 256.3 | 371.2 | 537.6 | 778.4 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | .2 | 25.2 | 120.3 | 71.4 | 153.2 | 111.9 | 185.7 | 268.9 | 389.4 | 563.9 |
WACC, % | 10.6 | 10.6 | 10.6 | 10.6 | 10.6 | 10.6 | 10.6 | 10.6 | 10.6 | 10.6 |
PV UFCF | ||||||||||
SUM PV UFCF | 1,052.6 | |||||||||
Long Term Growth Rate, % | 4.00 | |||||||||
Free cash flow (T + 1) | 586 | |||||||||
Terminal Value | 8,882 | |||||||||
Present Terminal Value | 5,366 | |||||||||
Enterprise Value | 6,419 | |||||||||
Net Debt | -82 | |||||||||
Equity Value | 6,501 | |||||||||
Diluted Shares Outstanding, MM | 206 | |||||||||
Equity Value Per Share | 31.60 |
What You Will Get
- Real DOCS Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed automatically.
- Scenario Analysis: Evaluate various scenarios to assess Doximity’s future performance.
- User-Friendly Design: Crafted for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Doximity, Inc. (DOCS).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to Doximity.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit Doximity's financial outlook.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Doximity, Inc. (DOCS).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for quick and effective analysis.
How It Works
- Download: Obtain the pre-configured Excel file containing Doximity, Inc.'s (DOCS) financial data.
- Customize: Modify projections such as revenue growth, EBITDA %, and WACC to fit your analysis.
- Update Automatically: Watch as the intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various forecasts and instantly compare the results.
- Make Decisions: Leverage the valuation insights to inform your investment approach.
Why Choose Doximity, Inc. (DOCS)?
- Streamlined Processes: Quickly access essential tools without the hassle of setup.
- Enhanced Precision: Utilize verified data and methodologies to minimize valuation discrepancies.
- Completely Adaptable: Modify the platform to suit your unique requirements and forecasts.
- User-Friendly Interface: Intuitive visualizations and outputs facilitate easy comprehension of results.
- Endorsed by Professionals: Crafted for experts who prioritize accuracy and functionality.
Who Should Use This Product?
- Investors: Accurately assess Doximity's fair value before making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis related to Doximity (DOCS).
- Consultants: Easily modify the template for valuation reports tailored to clients interested in Doximity (DOCS).
- Entrepreneurs: Acquire knowledge of financial modeling practices employed by leading companies like Doximity (DOCS).
- Educators: Implement it as a teaching resource to illustrate valuation techniques using Doximity (DOCS) as a case study.
What the Template Contains
- Pre-Filled Data: Features Doximity’s historical financials and projections.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Evaluate Doximity’s profitability, efficiency, and leverage.
- Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
- Clear Dashboard: Visuals and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.